España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
AIM ImmunoTech
AIM
AMEX
Watchlist
Leave a Comment
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.364900
0.0085
2.38%
At Close: -
15 minutes delayed
Get Report
Comment
AIM ImmunoTech (AIM) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for AIM ImmunoTech (AMEX:AIM) Stock
AIM ImmunoTech Stock (AMEX: AIM)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, July 24, 2024
AIM ImmunoTech Announces New Pre-Clinical Dat...
Benzinga Newsdesk
Friday, May 31, 2024
ImmunoTech Announces Pricing Of 5,640,958 Sha...
Benzinga Newsdesk
Thursday, May 16, 2024
AIM ImmunoTech Q1 2024 GAAP EPS $(0.12), Inli...
Benzinga Newsdesk
Monday, May 06, 2024
AIM ImmunoTech Completes cGMP Manufacturing O...
Benzinga Newsdesk
Monday, April 29, 2024
AIM ImmunoTech Complete Safety Evaluation Of ...
Benzinga Newsdesk
Wednesday, April 10, 2024
AIM ImmunoTech Announces Top-Line, Protocol-P...
Benzinga Newsdesk
Wednesday, April 03, 2024
AIM ImmunoTech Q4 EPS $(0.26) Misses $(0.15) ...
Benzinga Newsdesk
Tuesday, April 02, 2024
AIM ImmunoTech Reported Cash, Cash Equivalent...
Benzinga Newsdesk
Earnings Scheduled For April 2, 2024
Benzinga Insights
Monday, April 01, 2024
Preview: AIM ImmunoTech's Earnings
Benzinga Insights
Tuesday, March 26, 2024
Earnings Scheduled For March 26, 2024
Benzinga Insights
Monday, March 25, 2024
AIM ImmunoTech Announces Publication Of Findi...
Benzinga Newsdesk
AIM ImmunoTech And 3 Other Stocks Under $3 Insiders Are Buying
Avi Kapoor
Thursday, March 07, 2024
AIM ImmunoTech Launches CEO Corner Platform
Benzinga Newsdesk
Wednesday, February 14, 2024
AIM ImmunoTech Announces First Subject Dosed ...
Benzinga Newsdesk
Monday, February 12, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Thursday, February 08, 2024
AIM ImmunoTech Reports Topline Results From P...
Benzinga Newsdesk
Wednesday, January 24, 2024
AIM ImmunoTech Receives Erasmus Medical Cente...
Benzinga Newsdesk
Tuesday, January 23, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Monday, January 22, 2024
AIM ImmunoTech Announces That The First Subje...
Benzinga Newsdesk
Thursday, January 11, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Wednesday, January 10, 2024
AIM ImmunoTech Announces Open Enrollment For ...
Benzinga Newsdesk
Wednesday, January 03, 2024
Kellner Group Issued Statement In Connection ...
Benzinga Newsdesk
Friday, December 29, 2023
AIM ImmunoTech Says Delaware Court Rules In F...
Benzinga Newsdesk
Tuesday, November 28, 2023
AIM ImmunoTech And 3 Other Stocks Under $1 Insiders Are Buying
Lisa Levin
Monday, November 27, 2023
AIM ImmunoTech Issued Two US Patents Titled '...
Bill Haddad
Tuesday, November 21, 2023
AIM ImmunoTech Completes Treatment Of Last Su...
Benzinga Newsdesk
Wednesday, November 15, 2023
Earnings Scheduled For November 15, 2023
Benzinga Insights
AIM ImmunoTech Q3 EPS $(0.16) Misses $(0.11) ...
Benzinga Newsdesk
Tuesday, November 14, 2023
Preview: AIM ImmunoTech's Earnings
Benzinga Insights
AIM ImmunoTech Announces Publication Of Data ...
Benzinga Newsdesk
Wednesday, November 08, 2023
AIM ImmunoTech Announces Translational Data F...
Benzinga Newsdesk
Monday, November 06, 2023
AIM ImmunoTech Files Definitive Proxy Stateme...
Benzinga Newsdesk
Monday, October 30, 2023
AIM Immunotech Announces Abstract Accepted Fo...
Benzinga Newsdesk
Tuesday, October 17, 2023
AIM ImmunoTech Engages Business Development F...
Benzinga Newsdesk
Monday, October 02, 2023
NetSol Technologies And 2 Other Stocks Under $2 Insiders Are Buying
Lisa Levin
Monday, September 11, 2023
Why Is Cancer Focused Microcap Stock AIM ImmunoTech Trading Higher Today?
Vandana Singh
Tuesday, September 05, 2023
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Wednesday, August 23, 2023
Why AMC Entertainment Shares Are Trading Lower By 21%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Friday, August 18, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Wednesday, August 16, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Tuesday, August 15, 2023
AIM ImmunoTech Q2 EPS $(0.10) Beats $(0.11) E...
Benzinga Newsdesk
Earnings Scheduled For August 15, 2023
Benzinga Insights
Monday, August 14, 2023
Earnings Outlook For AIM ImmunoTech
Benzinga Insights
Friday, August 11, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Earnings Scheduled For August 11, 2023
Benzinga Insights
Thursday, August 10, 2023
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Wednesday, August 09, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Tuesday, August 08, 2023
AIM ImmunoTech Announces Completion Of Enrollment In Phase 2 Study Evaluating Ampligen For The Treatment Of Post-COVID Conditions
Happy Mohamed
Thursday, July 27, 2023
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
